KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash from Financing Activities (2016 - 2025)

Elevance Health (ELV) has disclosed Cash from Financing Activities for 16 consecutive years, with $236.0 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 83.24% to $236.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.7 billion through Dec 2025, down 245.68% year-over-year, with the annual reading at -$1.7 billion for FY2025, 245.68% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $236.0 million at Elevance Health, down from $243.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $3.4 billion in Q1 2021, with the low at -$1.9 billion in Q1 2025.
  • Average Cash from Financing Activities over 5 years is -$239.4 million, with a median of -$351.0 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities soared 457.36% in 2024, then tumbled 6065.62% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$1.3 billion in 2021, then soared by 80.38% to -$258.0 million in 2022, then tumbled by 52.71% to -$394.0 million in 2023, then skyrocketed by 457.36% to $1.4 billion in 2024, then tumbled by 83.24% to $236.0 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $236.0 million, $243.0 million, and -$308.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.